Read the client scenario and answer question.

COPD patient's chart - Nurse's Note (0800) 84-year-old male client with a chronic obstructive pulmonary disease (emphysema) history is admitted to the inpatient Med surge unit provider today. Upon admission, the client reports unusual increased shortness of breath and fatigue. The client is on 1 liter of oxygen via a nasal cannula; 02 saturation is 93%. The client's respiratory rate is 30 bpm with accessory muscle use, heart rate is 125 bpm, and blood pressure is 127/89 mmHg. The client has a barrel chest and extremities. On call provided paged, pending call back.

Identify listed assessment findings as expected or findings that need to be reported to the provider. Select only one answer per finding.

A) Prednisone:
Prednisone is a corticosteroid commonly used to reduce inflammation in conditions such as asthma. It is appropriate in this case for managing the asthma exacerbation, as steroids help to decrease airway inflammation and improve breathing. There is no immediate concern about prednisone in this client with both asthma and a history of heart failure.

B) Metoprolol:
Metoprolol is a beta-blocker, typically used for managing heart failure, hypertension, and arrhythmias. However, beta-blockers are generally avoided in asthma patients because they can exacerbate bronchospasm. In patients with asthma, beta-blockers can block beta-2 receptors in the lungs, leading to constriction of the airways and worsening respiratory symptoms.

C) Labetolol:
Labetolol is a beta-blocker with both alpha- and beta-blocking effects, which can help lower blood pressure and manage heart failure. While labetalol can also block beta-2 receptors, it has a relatively lower risk of causing bronchospasm compared to non-selective beta-blockers like metoprolol. However, it still poses some risk to patients with asthma. Given the patient's history of asthma, labetolol may still require caution, but it is generally considered safer than other beta-blockers.

D) Albuterol:
Albuterol is a bronchodilator used to relieve acute asthma symptoms and is commonly prescribed for asthma exacerbations. It works by stimulating beta-2 receptors in the lungs, leading to the relaxation of bronchial smooth muscles and improved airflow. In this case, albuterol is an appropriate medication for managing asthma exacerbation and should be used to relieve symptoms of shortness of breath and wheezing.

A) Assess for dislodgement and use forceps to retrieve the dislodged pellets and place in the lead container:
The priority action when a patient is receiving brachytherapy for uterine cancer is to assess for potential dislodgement of the radioactive implant. If the radiation source has been displaced, it must be handled carefully to prevent radiation exposure to the nurse, other patients, and staff. The nurse should use forceps to carefully retrieve the dislodged pellets and place them in a lead container to prevent contamination.

B) Assess the patient's knowledge of the treatment plan and her willingness to participate:
While it is important to assess the patient's understanding of the treatment plan and her willingness to participate, this is not the immediate priority in this situation. The nurse’s first priority is to address the potential risk of radiation exposure due to the dislodgement of the implant.

C) Assess the UAP's knowledge and explain the rationale for strict bed rest:
Although it is important for the nurse to ensure that all team members, including UAPs, understand the rationale for strict bed rest during brachytherapy, this action is not the most immediate priority in this scenario. The potential dislodgement of the radiation implant requires urgent assessment and intervention.

D) Notify the physician about the potential dislodgment of the radiation implant:
Notifying the physician about the dislodgement is an important step, but it is not the first action the nurse should take. The immediate priority is to assess and secure the radiation implant using appropriate protocols. Once the dislodged pellets have been safely contained in the lead container, the nurse should then notify the physician for further guidance on the next steps in treatment or care.